Skip to content
healthcare.dev

Ondansetron

NDC 43063-273, Ondansetron, tablet, orally disintegrating, from PD-Rx Pharmaceuticals, Inc..

Product NDC
43063-273
Status
Listed
Labeler
PD-Rx Pharmaceuticals, Inc.
Dosage form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA078152
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/43063-273 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ONDANSETRON8 mg/1

Pharmacologic classes

Serotonin 3 Receptor Antagonists [MoA]; Serotonin-3 Receptor Antagonist [EPC]

Package NDCNDC-11Package
43063-273-04430630273044 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE, PLASTIC (43063-273-04)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/d117de5f-64e5-464c-b782-de0f07e66c8e

Use it

Look up 43063-273 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/43063-273 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 43063-273. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.